Literature DB >> 29982580

Serological Evidence for the Circulation of Ebolaviruses in Pigs From Sierra Leone.

Kerstin Fischer1, Juliet Jabaty2, Roland Suluku3, Thomas Strecker4, Allison Groseth5, Sarah K Fehling4, Anne Balkema-Buschmann1, Bashiru Koroma3, Kristina M Schmidt1, Christine Atherstone6,7, Hana M Weingartl8, Thomas C Mettenleiter9, Martin H Groschup1, Thomas Hoenen9, Sandra Diederich1.   

Abstract

Many human ebolavirus outbreaks have been linked to contact with wildlife including nonhuman primates and bats, which are assumed to serve as host species. However, it is largely unknown to what extent other animal species, particularly livestock, are involved in the transmission cycle or act as additional hosts for filoviruses. Pigs were identified as a susceptible host for Reston virus with subsequent transmission to humans reported in the Philippines. To date, there is no evidence of natural Ebola virus (EBOV) infection in pigs, although pigs were shown to be susceptible to EBOV infection under experimental settings. To investigate the potential role of pigs in the ecology of EBOV, we analyzed 400 porcine serum samples from Sierra Leone for the presence of ebolavirus-specific antibodies. Three samples reacted with ebolavirus nucleoproteins but had no neutralizing antibodies. Our results (1) suggest the circulation of ebolaviruses in swine in Sierra Leone that are antigenically related but not identical to EBOV and (2) could represent undiscovered ebolaviruses with unknown pathogenic and/or zoonotic potential.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29982580     DOI: 10.1093/infdis/jiy330

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Reston virus causes severe respiratory disease in young domestic pigs.

Authors:  Elaine Haddock; Greg Saturday; Friederike Feldmann; Patrick W Hanley; Atsushi Okumura; Jamie Lovaglio; Dan Long; Tina Thomas; Dana P Scott; Mikayla Pulliam; Jürgen A Richt; Emmie de Wit; Heinz Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-21       Impact factor: 11.205

Review 2.  Therapeutic strategies to target the Ebola virus life cycle.

Authors:  Thomas Hoenen; Allison Groseth; Heinz Feldmann
Journal:  Nat Rev Microbiol       Date:  2019-07-24       Impact factor: 60.633

3.  Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone.

Authors:  Daniela Manno; Philip Ayieko; David Ishola; Muhammed O Afolabi; Baimba Rogers; Frank Baiden; Alimamy Serry-Bangura; Osman M Bah; Brian Köhn; Ibrahim Swaray; Kwabena Owusu-Kyei; Godfrey T Otieno; Dickens Kowuor; Daniel Tindanbil; Elizabeth Smout; Cynthia Robinson; Babajide Keshinro; Julie Foster; Katherine Gallagher; Brett Lowe; Macaya Douoguih; Bailah Leigh; Brian Greenwood; Deborah Watson-Jones
Journal:  Emerg Infect Dis       Date:  2022-03       Impact factor: 6.883

4.  Livestock and Risk Group 4 Pathogens: Researching Zoonotic Threats to Public Health and Agriculture in Maximum Containment.

Authors:  Charles E Lewis; Bradley Pickering
Journal:  ILAR J       Date:  2022-01-07

5.  Ebola Virus Glycoprotein Domains Associated with Protective Efficacy.

Authors:  Bharti Bhatia; Wakako Furuyama; Thomas Hoenen; Heinz Feldmann; Andrea Marzi
Journal:  Vaccines (Basel)       Date:  2021-06-10

6.  Ebola Virus Neutralizing Antibodies in Dogs from Sierra Leone, 2017.

Authors:  Kerstin Fischer; Roland Suluku; Sarah Katharina Fehling; Juliet Jabaty; Bashiru Koroma; Thomas Strecker; Martin H Groschup; Sandra Diederich
Journal:  Emerg Infect Dis       Date:  2020-04       Impact factor: 6.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.